News | August 05, 2021
Caplin Point Laboratories posts consolidated PAT in Q1FY22 at Rs 70.85 Cr
EPS climbs to Rs 9.25 for the quarter
EPS climbs to Rs 9.25 for the quarter
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
AstraZeneca, Sinopharm and Moderna were part of the study
It is part of the company’s pain/analgesics portfolio of OTC products
Apollo hospital-Hyderabad, Kainos Hospital-Rohtak and Apex Hospital Jaipur have deployed this solution
Aditya Puri former MD of HDFC bank joins Solara board as chairman
Startup receives US $ 5 million in first round of funding
Five seats reserved for Wards of COVID warriors in central MBBS admission
It is designed to tackle mental health issues
Drug formulations and biologics make impressive gains
Subscribe To Our Newsletter & Stay Updated
